GlassScriptPhysician profile
David R Miklos
NPI 1609146984
$3,004.69
in general payments reported to CMS, 2019-2025
20 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $283 · 2021: $344 · 2022: $399 · 2023: $675 · 2024: $330 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $538.29 | 2020-2025 | Augment Injectable, Alphavent, Iconix |
| Smith+Nephew, INC. | $520.98 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Osteomed LLC | $408.80 | 2019-2022 | |
| Acumed LLC | $372.15 | 2019-2024 | Osteomed, Acumed |
| Orthofix Medical, INC. | $333.83 | 2021-2025 | Physio-Stim |
| Abbott Laboratories | $155.27 | 2022 | |
| Wright Medical Technology, INC. | $110.94 | 2019 | |
| Medtronic, INC. | $105.24 | 2021 | |
| Acera Surgical, INC. | $88.06 | 2019-2022 | |
| Horizon Therapeutics Plc | $67.72 | 2019-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $54.36 | 2019 | |
| Polarityte, INC. | $44.43 | 2019-2020 | |
| Kuros Biosciences USA, INC | $43.26 | 2025 | Magnetos |
| Solventum Corporation | $29.16 | 2024 | |
| Alfasigma USA, INC. | $27.80 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $26.21 | 2020 | |
| Osiris Therapeutics INC. | $22.95 | 2019 | |
| Misonix INC | $21.87 | 2019 | |
| Mimedx Group, INC. | $20.10 | 2025 | |
| Integra Lifesciences Corporation | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miklos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.